Nathaniel Calloway - 01 Nov 2022 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Director
Signature
/s/ James R. Merchant, Attorney-in-Fact
Issuer symbol
ANEB
Transactions as of
01 Nov 2022
Net transactions value
$0
Form type
4
Filing time
02 Nov 2022, 16:31:58 UTC
Previous filing
02 Nov 2022
Next filing
11 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Stock Option (right to buy) Award $0 +59,149 $0.000000 59,149 01 Nov 2022 Common Stock 59,149 $2.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the original number of shares vest on the first anniversary of November 1, 2022 (the "Vesting Commencement Date") and 2.0833% of the original number of shares vest at the end of each successive month following the first anniversary of the Vesting Commencement Date until the fourth anniversary of the Vesting Commencement Date.